Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$4.66 - $6.52 $1,043 - $1,460
-224 Reduced 28.18%
571 $3,000
Q4 2022

Feb 14, 2023

SELL
$3.7 - $5.29 $3 - $5
-1 Reduced 0.13%
795 $3,000
Q3 2022

Nov 14, 2022

SELL
$2.72 - $4.61 $3.67 Million - $6.22 Million
-1,348,669 Reduced 99.94%
796 $3,000
Q2 2022

Aug 12, 2022

SELL
$2.71 - $7.12 $10.2 Million - $26.9 Million
-3,773,869 Reduced 73.66%
1,349,465 $3.66 Million
Q1 2022

May 16, 2022

BUY
$6.62 - $9.33 $1.67 Million - $2.35 Million
251,955 Added 5.17%
5,123,334 $34.7 Million
Q4 2021

Feb 07, 2022

BUY
$8.3 - $11.29 $5.28 Million - $7.18 Million
635,793 Added 15.01%
4,871,379 $42.3 Million
Q3 2021

Nov 15, 2021

BUY
$9.73 - $13.38 $2.01 Million - $2.77 Million
206,948 Added 5.14%
4,235,586 $47.9 Million
Q2 2021

Aug 16, 2021

BUY
$9.02 - $11.68 $3.22 Million - $4.17 Million
357,233 Added 9.73%
4,028,638 $40.9 Million
Q1 2021

May 17, 2021

BUY
$9.53 - $15.42 $6.05 Million - $9.79 Million
634,826 Added 20.91%
3,671,405 $42.8 Million
Q4 2020

Feb 16, 2021

BUY
$10.35 - $15.94 $22.2 Million - $34.2 Million
2,145,992 Added 240.96%
3,036,579 $32.1 Million
Q3 2020

Nov 16, 2020

BUY
$10.24 - $19.58 $1.82 Million - $3.48 Million
177,722 Added 24.93%
890,587 $10.8 Million
Q2 2020

Aug 13, 2020

SELL
$9.71 - $17.87 $1.3 Million - $2.39 Million
-133,834 Reduced 15.81%
712,865 $8.29 Million
Q1 2020

May 14, 2020

BUY
$5.57 - $10.76 $39,285 - $75,890
7,053 Added 0.84%
846,699 $9.11 Million
Q4 2019

Feb 07, 2020

BUY
$7.21 - $8.89 $621,941 - $766,860
86,261 Added 11.45%
839,646 $6.74 Million
Q3 2019

Nov 14, 2019

BUY
$6.57 - $9.46 $4.95 Million - $7.13 Million
753,385 New
753,385 $5.63 Million

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $282M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Earnest Partners LLC Portfolio

Follow Earnest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.